TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
INBX

Inhibrx Biosciences, Inc.

Healthcare · Biotechnology

104.70$ +2.9% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Inhibrx Biosciences, Inc. (INBX): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/12/2026.

Next report 08/12/2026
Last report 08/13/2026
Earnings surprise by quarter (%)
Q1 24 · -38.5 % 24 Q2 24 · 8,355.3 % 24 Q3 24 · 23.2 % 24 Q4 24 · -114.6 % 24 Q1 25 · 10.3 % 25 Q2 25 · 28.9 % 25 Q3 25 · -32.6 % 25 Q4 25 · -29.5 % 25 Q1 26 · -79.2 % 26 Q2 26 · 6.4 % 26

EPS estimate beaten

Full history 5 of 10 quarters (50%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 09/08/2026 Inhibrx Biosciences, Inc. (INBX): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/13/2026 Inhibrx Biosciences, Inc. (INBX): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/16/2026 Inhibrx Biosciences, Inc. (INBX): Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Unregistered Sales of Equity Securities; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?